rs113994102

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4

The NM_004715.5(CTDP1):​c.863+389C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 26)

Consequence

CTDP1
NM_004715.5 intron

Scores

2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6O:1

Conservation

PhyloP100: -1.29
Variant links:
Genes affected
CTDP1 (HGNC:2498): (CTD phosphatase subunit 1) This gene encodes a protein which interacts with the carboxy-terminus of the RAP74 subunit of transcription initiation factor TFIIF, and functions as a phosphatase that processively dephosphorylates the C-terminus of POLR2A (a subunit of RNA polymerase II), making it available for initiation of gene expression. Mutations in this gene are associated with congenital cataracts, facial dysmorphism and neuropathy syndrome (CCFDN). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-79710825-C-T is Pathogenic according to our data. Variant chr18-79710825-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 5301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-79710825-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTDP1NM_004715.5 linkc.863+389C>T intron_variant Intron 6 of 12 ENST00000613122.5 NP_004706.3 Q9Y5B0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTDP1ENST00000613122.5 linkc.863+389C>T intron_variant Intron 6 of 12 1 NM_004715.5 ENSP00000484525.2 Q9Y5B0-1
CTDP1ENST00000075430.11 linkc.863+389C>T intron_variant Intron 6 of 11 1 ENSP00000075430.7 Q9Y5B0-4
CTDP1ENST00000591598.5 linkc.659+389C>T intron_variant Intron 6 of 11 1 ENSP00000465119.1 K7EJD2

Frequencies

GnomAD3 genomes
Cov.:
26
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
26

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Mar 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 14517542). This sequence change falls in intron 6 of the CTDP1 gene. It does not directly change the encoded amino acid sequence of the CTDP1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with congenital cataracts, facial dysmorphism, and neuropathy (PMID: 14517542, 23408394, 24690360, 29174527). It is commonly reported in individuals of Romani ancestry (PMID: 24690360, 29174527). ClinVar contains an entry for this variant (Variation ID: 5301). -

-
Clinical Genetics, Academic Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CTDP1: PM3:Very Strong, PM2, PS3:Supporting -

Congenital cataracts-facial dysmorphism-neuropathy syndrome Pathogenic:1Other:1
Oct 01, 2004
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Charcot-Marie-Tooth disease Pathogenic:1
-
Inherited Neuropathy Consortium
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
4.7
DANN
Benign
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113994102; hg19: chr18-77470825; API